title: SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway.
abstract: Secreted protein acidic and rich in cysteine (SPARC) participates in the regulation of morphogenesis and cellular differentiation through its modulation of cell-matrix interactions. We previously reported that SPARC expression significantly impairs medulloblastoma tumor growth in vivo. In this study, we show that adenoviral-mediated overexpression of SPARC cDNA (Ad-DsRed-SP) elevated the expression of the neuronal markers NeuN, nestin, neurofilament, and MAP-2 in medulloblastoma cells and induced neuron-like differentiation. SPARC overexpression decreased STAT3 phosphorylation; constitutive expression of STAT3 reversed SPARC-mediated expression of neuronal markers. We also show that Notch signaling is suppressed in the presence of SPARC, as well as the Notch effector basic helix-loop-helix (bHLH) transcription factor hairy and enhancer of split 1 (HES1). Notch signaling was found to be responsible for the decreased STAT3 phosphorylation in response to SPARC expression. Furthermore, expression of SPARC decreased the production of interleukin 6 (IL-6) and supplemented IL-6-abrogated, SPARC-mediated suppression of Notch signaling and expression of neuronal markers. Immunohistochemical analysis of tumor sections from mice treated with Ad-DsRed-SP showed increased immunoreactivity for the neuronal markers and a decrease in Notch1 expression and phosphorylation of STAT3. Taken together, our results suggest that SPARC induces expression of neuronal markers in medulloblastoma cells through its inhibitory effect on IL-6-regulated suppression of Notch pathway-mediated STAT3 signaling, thus giving further support to the potential use of SPARC as a therapeutic candidate for medulloblastoma treatment. Findings show that SPARC-induced neuronal differentiation can sensitize medulloblastoma cells for therapy.
authors: Program of Cancer Biology, Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
authors: Praveen
authors: P
authors: Bhoopathi
authors: Chandramu
authors: C
authors: Chetty
authors: Ranadheer
authors: R
authors: Dontula
authors: Meena
authors: M
authors: Gujrati
authors: Dzung H
authors: DH
authors: Dinh
authors: Jasti S
authors: JS
authors: Rao
authors: Sajani S
authors: SS
authors: Lakka
references: Exp Cell Res. 1993 Jun;206(2):261-75
references: 8500547
references: FASEB J. 1994 Feb;8(2):163-73
references: 8119487
references: Oncogene. 2007 Dec 6;26(55):7675-83
references: 17599056
references: Biochem Biophys Res Commun. 2000 May 19;271(3):630-4
references: 10814513
references: Cell Death Differ. 2010 Oct;17(10):1529-39
references: 20339379
references: Cancer Res. 1990 Apr 15;50(8):2347-50
references: 2180567
references: Cancer Res. 2005 Jun 15;65(12):4975-8
references: 15958535
references: J Dent Res. 2007 Apr;86(4):296-305
references: 17384023
references: Protein Sci. 2006 Feb;15(2):335-42
references: 16385004
references: Lancet Neurol. 2007 Dec;6(12):1073-85
references: 18031705
references: J Cell Sci. 2008 May 15;121(Pt 10):1671-80
references: 18445681
references: Cancer Res. 2004 Nov 1;64(21):7787-93
references: 15520184
references: Dev Growth Differ. 1999 Aug;41(4):407-18
references: 10466928
references: Nat Cell Biol. 2004 Jun;6(6):547-54
references: 15156153
references: Development. 2006 Jul;133(13):2553-63
references: 16728475
references: Neoplasia. 2008 Jul;10(7):736-44
references: 18592012
references: Cancer Res. 1990 Nov 1;50(21):6976-80
references: 2208164
references: Biochem Biophys Res Commun. 2010 Feb 26;393(1):144-9
references: 20117093
references: Science. 1997 Oct 17;278(5337):477-83
references: 9334309
references: Cancer Res. 2006 Aug 1;66(15):7445-52
references: 16885340
references: J Clin Oncol. 1999 Mar;17(3):832-45
references: 10071274
references: Acta Neuropathol. 2007 Aug;114(2):97-109
references: 17618441
references: J Neurosci. 2009 Mar 11;29(10):3288-301
references: 19279266
references: Neoplasia. 2007 Jan;9(1):23-35
references: 17325741
references: Biomaterials. 2006 Jul;27(20):3825-35
references: 16564084
references: J Clin Invest. 2007 Dec;117(12):3988-4002
references: 18060036
references: Nature. 1995 Sep 14;377(6545):115-8
references: 7675078
references: Biochim Biophys Acta. 2002 Nov 11;1592(3):323-43
references: 12421676
references: Eur J Cancer. 2005 Nov;41(16):2502-12
references: 16199153
references: Int J Cancer. 2006 Jan 15;118(2):310-6
references: 16052522
references: Neuron. 2008 Apr 10;58(1):52-64
references: 18400163
references: J Clin Invest. 2005 Jun;115(6):1492-502
references: 15902309
references: EMBO J. 1999 Aug 2;18(15):4261-9
references: 10428964
references: J Biol Chem. 2008 Jan 18;283(3):1545-1552
references: 17991734
references: Annu Rev Immunol. 2005;23:945-74
references: 15771590
references: J Neurosci Res. 2005 Jul 15;81(2):163-71
references: 15948155
references: Cancer Chemother Biol Response Modif. 1994;15:337-66
references: 7779589
references: J Histochem Cytochem. 1999 Dec;47(12):1495-506
references: 10567433
references: Biochem Cell Biol. 2008 Dec;86(6):487-99
references: 19088797
references: Nat Med. 2000 Jul;6(7):826-31
references: 10888935
references: J Immunol. 2002 Sep 15;169(6):2956-63
references: 12218109
references: J Pathol. 2006 Mar;208(4):554-63
references: 16400626